Oscotec to Present Kidney Failure Treatment Candidate at World Congress of Nephrology in Japan
Oscotec announced on the 23rd that it will present animal-model proof-of-concept results for a new drug candidate series, the OCT-648 program, at the...
Search results for "patient safety"
Alteogen to Present Subcutaneous ADC Formulation Research at International Forum in June
Alteogen announced on the 23rd that it will present research results regarding subcutaneous dosing for antibody-drug conjugate therapies at the...
Celltrion Secures Canadian Approval for ‘Steqeyma’ Autoinjector Formulation
Celltrion announced on March 20, 2026, that it has received additional approval from Health Canada for the autoinjector...
A Single Cancer Shot: Local Injection Triggers Systemic Tumor Disappearance
For decades, one immuno-oncology strategy has held immense promise while repeatedly falling short: the use of CD40...
At 63, Demi Moore’s Timeless Appearance Sparks Debate: The True Cost of Hollywood Beauty?
Hollywood icon Demi Moore recently captivated fans by sharing a video update on social media, showcasing a remarkably...
A World-Class Orthopedic Powerhouse Built on Patient Trust
Early last year, the Netflix medical drama The Trauma Code: Heroes on Call captivated global audiences, racking up 11.
Global Competition to Cultivate 'Good Doctors' Transforms Medical Classrooms
From Technical Instruction to Patient-Centered Care “How do you tell a patient they have terminal cancer.
Restoring the Breath of Night: The Potential for a Sleep Apnea Pill
Obstructive sleep apnea , a condition where breathing repeatedly stops during sleep, is far more than a mere snoring...
GLP-1 Drugs and Bone Health: Studies Highlight Fracture Risks in Elderly Patients
The GLP-1 receptor agonist class of drugs, widely used for the treatment of obesity and type 2 diabetes, has...
SK Chemicals Launches High-Dose 300 mg Joins for Osteoarthritis Treatment
SK Chemicals has announced the release of a new high-dose version of Joins, its flagship natural product-based...